BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia
Blood Immunology & Cellular Therapy
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000321?dgcid=rss_sd_all
BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000321?dgcid=rss_sd_all
“BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia.” Blood Immunology & Cellular Therapy.
@article{article38487,
title = {BCMA-targeted T-cell engager therapy induces sustained remission in immune thrombocytopenia},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000321?dgcid=rss_sd_all}
}